The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Extramedullary disease in multiple myeloma: a systematic literature review
Open accessAbstract
Extramedullary involvement (or extramedullary disease, EMD) represents an aggressive form of multiple myeloma (MM), characterized by the ability of a clone and/or subclone to thrive and grow independent of the bone marrow microenvironment. Several different definitions of EMD have been used in the published literature. We advocate that true EMD is restricted to soft-tissue plasmacytomas that arise due to hematogenous spread and have no contact with bony structures. Typical sites of EMD vary according to the phase of MM. At diagnosis, EMD is typically found in skin and soft tissues; at relapse, typical sites involved include liver, kidneys, lymph nodes, central nervous system (CNS), breast, pleura, and pericardium. The reported incidence of EMD varies considerably, and differences in diagnostic approach between studies are likely to contribute to this variability. In patients with newly diagnosed MM, the reported incidence ranges from 0.5% to 4.8%, while in relapsed/refractory MM the reported incidence is 3.4 to 14%. Available data demonstrate that the prognosis is poor, and considerably worse than for MM without soft-tissue plasmacytomas. Among patients with plasmacytomas, those with EMD have poorer outcomes than those with paraskeletal involvement. CNS involvement is rare, but prognosis is even more dismal than for EMD in other locations, particularly if there is leptomeningeal involvement. Available data on treatment outcomes for EMD are derived almost entirely from retrospective studies. Some agents and combinations have shown a degree of efficacy but, as would be expected, this is less than in MM patients with no extramedullary involvement. The paucity of prospective studies makes it difficult to justify strong recommendations for any treatment approach. Prospective data from patients with clearly defined EMD are important for the optimal evaluation of treatment outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, patients with advanced disease stage (R-ISS stage III) have consistently shown poorer outcomes irrespective of the therapy received4–6,19–22.”
From Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results (2023) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.-V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70442-5 · Cited by 4,978
Self-citationKumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M.-V., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30206-6 · Cited by 3,061
Self-citationIdecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
Munshi, N. C., Anderson, L. D., Shah, N., Madduri, D., Berdeja, J., Lonial, S., Raje, N., Lin, Y., Siegel, D., Oriol, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2024850 · Cited by 2,560 · cited 1×
“Published trials of other CAR-T therapies have reported responses in patients with soft-tissue plasmacytomas, but do not report data specifically for patients with EMD [44, 45].”
BackgroundSelf-citationAnti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma.
Raje, N., Berdeja, J., Lin, Y., Siegel, D., Jagannath, S., Madduri, D., Liedtke, M., Rosenblatt, J., Maus, M. V., Turka, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817226 · Cited by 1,730
Cavo, M., Terpos, E., Nanni, C., Moreau, P., Lentzsch, S., Zweegman, S., Hillengaß, J., Engelhardt, M. M., Usmani, S. Z., Vesole, D. H., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30189-4 · Cited by 547
Self-citationVarettoni, M., Corso, A., Pica, G.-M., Mangiacavalli, S., Pascutto, C., & Lazzarino, M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp329 · Cited by 489
Usmani, S. Z., Heuck, C. J., Mitchell, A., Szymonifka, J. D., Nair, B. P., Hoering, A., Alsayed, Y. M., Waheed, S., Haider, S., Restrepo, A., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.065698 · Cited by 395
Self-citationBladé, J., de Larrea, C. F., Rosiñol, L., Cibeira, M. T., Jiménez, R., & Powles, R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.9290 · Cited by 388
Self-citationde Larrea, C. F., Kyle, R. A., Durie, B. G. M., Ludwig, H., Usmani, S. Z., Vesole, D. H., Hájek, R., Miguel, J. F. S., Sezer, O., Sonneveld, P., et al. (2012) · Leukemia · doi:10.1038/leu.2012.336 · Cited by 384
Self-citationCaers, J., Paiva, B., Zamagni, E., Leleu, X. P., Bladé, J., Kristinsson, S. Y., Touzeau, C., Abildgaard, N., Terpos, E., Heusschen, R., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0549-1 · Cited by 338
Self-citation
Cited by
Sorted by citations
Items 201–300 of 319
Filippi, L., Urso, L., Ferrari, C., Bauckneht, M., Albano, D., Maffione, A. M., Aricò, D., Panareo, S., & Evangelista, L. (2024) · Clinical and Translational Imaging · doi:10.1007/s40336-024-00648-x
Çiftçiler, R., Çiftçiler, A. E., & Dağlı, M. (2024) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-024-01820-z
Jachimowski, P., Ciulkiewicz, Ł., Wróblewska, B., Grabowska-Derlatka, L., Basak, G. W., & Ziarkiewicz, M. (2024) · Current Problems in Cancer Case Reports · doi:10.1016/j.cpccr.2024.100324
High-Risk Myeloma: Definitions and Treatments
Sharma, R., Sanchez-Hernandez, K. A., & Lancman, G. (2024) · Canadian Hematology Today · doi:10.58931/cht.2024.3254
A rare case of CD38-negative abdominal multiple extramedullary plasmacytoma and literature review
Bao, X., Gong, D., Zhou, K., & Huang, W. (2024) · Leukemia Research Reports · doi:10.1016/j.lrr.2024.100493
Yogendra, P. M., Nickalls, O. J., & Ho, C. L. (2025) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/0115734056340774241227080230
Development Trends in the Clinical Test of Multiple Myeloma from 2000 to 2023: A Bibliometric Study
Wu, H., Sun, H., Wang, Y., Lv, Z., Li, Y., Su, F., Liu, C., Chen, Y., Shi, K., Zhao, P., et al. (2025) · doi:10.69638/jmmr20210110x
Immuntherapien des multiplen Myeloms
Kadel, S., & Rasche, L. (2025) · Die Onkologie · doi:10.1007/s00761-024-01658-0
Self-citationGowell, M., & Morrow, A. A. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-261990
Plasma Cell Neoplasms and Paraproteinemias: Cutaneous Manifestations and Their Benign Mimics
Gniadecki, R., Taparia, M. S., Deschênes, J., Hardin, J., & Mahé, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-65292-9_4
Issa, J. A., Vusqa, U. T., Behling, E. M., Budak-Alpdoǧan, T., & Ghimire, S. (2025) · Cureus · doi:10.7759/cureus.81602
Making Sense of Incidental Musculoskeletal Findings on Breast MRI
Wojack, P. R., McElligott, S. E., Walsh, P., Vincoff, N. S., & Gupta, E. (2024) · Applied Radiology · doi:10.37549/ar2990
Guo, J., & Huang, X. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07283-2
Ultrasonographic Features of Plasmablastic Plasmacytoma of the Breast: A Case Report
Chen, C., Xu, Q., Yang, Y., Xu, X., Liu, E., Li, X., & Liu, L. (2025) · Journal of Clinical Ultrasound · doi:10.1002/jcu.24049
Liang, D., Yan, Y., Bai, S., Xu, W., Wang, Q., Feng, D., Bu, Y., Zeng, M., Nie, X., Feng, Y., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2496796
Hernández-Sigüenza, J. C., Blanco-Gímenez, P., Baraja-Vegas, L., López-Soler, J., Falaguera-Vera, F. J., Jaenada-Carrilero, E., & Mampel, J. V. (2025) · Current Oncology · doi:10.3390/curroncol32050282
Brinkert, K., Heinrich, B., Brioli, A., Heuser, M., Kreipe, H. H., Heidel, F. H., Ganser, A., & Beutel, G. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06489-6
Which Calculations Are Required for Treating Patients with Multiple Myeloma?
Лучинин, А. С., & Semenova, A. (2025) · Clinical oncohematology · doi:10.21320/2500-2139-2025-18-3-218-226
Yadav, K., Mohan, M., Wagner, C. B., Chakraborty, R., Sborov, D. W., Godara, A., McClune, B. L., Schinke, C., Dhakal, B., D’Souza, A., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02702-7
Lingaraju, T. K., Panda, B. B., Sethy, M., & Achanta, S. L. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i26.108409
Chen, Y., Cai, Q., Qiu, Z., Geng, H., Li, Y., Zhan, R., & Zheng, Z. (2025) · Journal of Chemotherapy · doi:10.1080/1120009x.2025.2540172
Network analysis of master regulators associated with invasive phenotypes in multiple myeloma
Feng, Q., Wang, Y., & Shi, Q. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1586870
He, J., Chiang, K., Lin, X., Kwong, W. J., Maringwa, J. T., Yang, L., Nair, S. C., Hashim, M., Keng, M. J., & Samjoo, I. A. (2025) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2024-0180
Limaïem, F., Gharbi, M. A., & Bouzidi, R. (2025) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2025.111829
Fatigue as main symptom in an elderly multiple myeloma patient: a Case Report
Li, X., Li, S., & Chen, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1635403 · Cited by 1
Multiples Myelom: Tumorheterogenität und Immunescape außerhalb des Knochenmarks
Weinhold, N., & Rasche, L. (2025) · Deutsches Ärzteblatt · doi:10.3238/personko.2025.09.05.01
Self-citationGaddipati, S., Sandhu, S., & Martin, E. F. (2025) · JGH Open · doi:10.1002/jgh3.70239
Mawlong, A., Kalita, P., Sethi, H. S., Raphael, V., Hynniewta, Y., Das, S., Kumar, R. N., Dey, B., Roy, A., & Marbaniang, R. S. (2025) · Cureus · doi:10.7759/cureus.91370
Novellis, D. D., Palmieri, S., Rocco, S., Derudas, D., Pepa, R. D., Roccotelli, D., Esposito, D., Masucci, C., Gigliotta, E., Barone, M. L., et al. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06572-y
Pu, Z., Zhan, L., Zha, Y., Li, Y., Qiu, S., He, Y., Yang, Y., Feng, Z., & Zhu, X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1640981
González-Resina, R., Rodríguez-Carpio, R. R., & Molias, A. C. G. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2025.107049
Mudawi, D., Al-Mashdali, A. F., Tawalbeh, A., Szabados, L., Soliman, D. S., & Fareed, S. (2025) · Kompass Onkologie · doi:10.1159/000548006
Baker, C., Hill, E., Kazandjian, D. G., Papadimitriou, M., Durante, M. A., Pandey, A., Ziccheddu, B., Jelı́nek, T., Coffey, D. G., Walker, B. A., et al. (2025) · HemaSphere · doi:10.1002/hem3.70367
Myelomatous pleural effusion: a rare initial manifestation of multiple myeloma
Li, G., Liu, Y., Pang, M., Wang, P., Guo, S.-J., & Jiang, G. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202505-1050im
Li, W., Tian, W.-W., Ma, J., Li, L., Li, Z., Liu, J., Gao, G., Xi, Z., Zhang, L., Zhang, W., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7484907/v1
Fan, K. D., Mahmoud, M., Madi, M. Y., Rocca, A. C., & Kiwan, W. (2025) · ACG Case Reports Journal · doi:10.14309/crj.0000000000001837
Unlocking myeloma's spatial world at the micrometer scale.
Rasche, L., & Weinhold, N. (2025) · Blood · doi:10.1182/blood.2025030205
Self-citationDirican, C. D., Ajayi, F., Mardini, A., Bijoy, S., Shaaban, H. S., & Guron, G. K. (2025) · Frontiers in Hematology · doi:10.3389/frhem.2025.1655966
Big spleens, low counts: a new prognostic signal in BCMA-directed CAR T-cell therapy
Alhomoud, M., & Rejeski, K. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.09.011
Mutlu, Y. G., Ünsal, Ş. E., Güleç, B., Serin, İ., Davulcu, E. A., Sönmez, G. M., Güven, S., Kaya, S. Y., Maral, S., Keklık, M., et al. (2025) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2025.10.006
Developing antisense therapeutics for multiple myeloma
Kapphahn, A., Truong, N., Khan, M., Ashitey, A., Alfano, D., & Gupta, A. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102923
Wang, Y., Xie, F., Cai, Y., & Xiang, P. (2025) · Pharmacognosy Magazine · doi:10.1177/09731296251388240
Aydin, C., Kibar, A., Kırkızlar, H. O., Altuntas, D., Üstün, F., & Sarıkaya, A. (2025) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-025-00971-9
Case Report: Genomic characterization of a rare skull-base plasmacytoma
Alanya, H., Kasturi, S., Yalcin, K., Gültekin, B., Kumar, D., Samuel, N., Figuera, D. S., Mishra-Gorur, K., Günel, M., Erson-Omay, Z., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1645502
Ng, Y. Y., Tang, H. H. W., & Wu, T. K. Y. (2025) · Radiology Case Reports · doi:10.1016/j.radcr.2025.10.079
Redefining Cure in Multiple Myeloma: Are We Chasing a Moving Target?
Kitundu, J. H. (2025) · Health Science Reports · doi:10.1002/hsr2.71581 · Cited by 2
Raharjo, B., Linggawan, S., Dumilah, H. D., Raharjo, Y. T., Gunawan, C. K., Sumarpo, A., Nugraha, J., & Bintoro, S. U. Y. (2025) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2025.033.4(special).02
Mediastinal Extramedullary Plasmacytoma in the Absence of Classical Myeloma Markers: A Case Report
Torres, G., Brito, A. P., Teixeira, H., Cotter, J., & Mota, P. (2025) · Cureus · doi:10.7759/cureus.99530
Bu, Q., Jiang, Y., Deng, J., Wang, P., Zhang, Z., Yang, G., Tian, Y., Gao, W., Liu, A., Leng, Y., et al. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.12.008
Hematologic focal hepatic lesions in the absence of liver cirrhosis: Consider lymphoma and myeloma
Tirotta, D., Lena, C., Torre, M., & Muratori, P. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102749
Multiple myeloma mimicking olfactory sulcus meningioma: Case report and literature review
Jiménez, D. J. M., Carballo, L. A. C. R., Baldoncini, M., Sevlever, G. E., & Demichelis, M. E. (2025) · Neurocirugía (English Edition) · doi:10.1016/j.neucie.2025.500731
Zanwar, S., Sidana, S., Shune, L. O., Puglianini, O. C., Pasvolsky, O., Gonzalez, R. M., Dima, D., Afrough, A., Kaur, G., Davis, J. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25989177
Jiménez, D. J. M., Carballo, L. J., Baldoncini, M., Sevlever, G. E., & Demichelis, M. E. (2025) · Neurocirugía · doi:10.1016/j.neucir.2025.500731
BADELITA, S. N., Barbu, S., Dobrea, C. M., Jardan, C., Popescu, M., Popa, C. D., Toma, C., Zidaru, L. E., Himcinschi, M., Sandu, H. M., et al. (2025) · Cancers · doi:10.3390/cancers18010019
A case report of testicular plasmacytoma misdiagnosed as lymphoma by ultrasound
Yu, D., & Xue, N. (2026) · Urology Case Reports · doi:10.1016/j.eucr.2026.103345
Meng, S., Liu, H., Gu, L., Wang, J., Wang, J., & Zhao, W. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06740-8
Shen, J., Cai, Y., Ouyang, H., & Zhong, X. (2026) · Medicine · doi:10.1097/md.0000000000047258
Orbital Plasmacytoma as the Initial Presentation of Multiple Myeloma: A Case Report
Panossian, A., Verhaegh, T., & Namavar, A. A. (2026) · Cureus · doi:10.7759/cureus.102225
Sahara, N., Matsunaga, T., Chie, G., Mizusawa, M., Miura, Y., Kobayashi, S., Fujii, T., & Ohno, N. (2026) · International Journal of Hematology · doi:10.1007/s12185-026-04172-8
Hu, X., Yang, M., Qi, Y., Dai, X., Huang, A., Chen, J., Jiang, X., Li, X., Zhao, H., Lu, J., et al. (2026) · Cancer Management and Research · doi:10.2147/cmar.s552024
Mosquera, D., Carballo, L. J., Baldoncini, M., & Demichelis, M. E. (2025) · Revista Argentina de Neurocirugía · doi:10.59156/revista.v39i02.734
Xu, H., Chen, X., Wang, W., Dong, S., Su, H., Zhen, P., Nie, X., & Hua, Q. (2026) · Discover Oncology · doi:10.1007/s12672-026-04616-x
Fan, H., Wu, Y., Peng, Y., Wang, L., Tu, S.-K., Peng, H., Yang, J., Li, X., Shi, Z., Li, M. S., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07861-4
Myelomatous Meningitis: a Report of Six Cases from a Single Centre
Aravindhakshan, A., Thambi, S. M., Narayanan, G., & Mony, R. P. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-026-02347-1
An Unusual Pattern of Hepatic Involvement in Plasma Cell Leukemia
Paz, M. A., Hamed, A., Ehster, C., Schat, R., Gupta, S., Younes, I. E., & Park, B. U. (2026) · Cureus · doi:10.7759/cureus.104296
Li, L., Zheng, W., Yu, M., Xu, J., Bai, S., Liu, Y., Wang, Y., & Cui, S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1793707
Plasmocitoma renoureteral bilateral. Una presentación inusual en paciente joven con mieloma múltiple
Ruiz, S., Compte, A., Mont-Castro, L. L., Pinilla, L., Tovar, D., Riera, E., & Garcia, J. R. (2026) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2026.500308
Diffuse Hepatic, Splenic, and Osseous Activity Due to Multiple Myeloma
Zhao, X., Liang, H., Zhao, G., Wei, L., & Xie, P. (2026) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000006410
Kavarthapu, S., Jakka, S. D., Singh, D., Nalamolu, V. K. S., & Nag, R. (2026) · Journal of Rare Diseases · doi:10.1007/s44162-026-00183-5
Mardelle, U. (2024) · theses.fr (ABES) · doi:10.70675/1e786d9ez8d0ez41b3z8ac1z367faf59ae53
Liu, Y., Mo, C. C., Midha, S., Hartley-Brown, M. A., Lee, H. C., Franz, J. K., Nadeem, O., Nicholson, T., Salman, T. J., Fortune, A., et al. (2026) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2026.2660911
Self-citationIto, S., Namiki, T., Nukariya, H., Endo, T., Sugawasa, Y., Ichinohe, T., Kurihara, K., Hamada, T., Otake, S., Takahashi, H., et al. (2026) · International Journal of Hematology · doi:10.1007/s12185-026-04216-z
Jung, O., Beauvais, D. M., Ibaan, G. L., Wooldrik, C., Flietner, E., Choi, S., Zhang, J., & Rapraeger, A. C. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02709-1
Staged Surgical Resection of Giant Multicentric Cranial Plasma Cell Neoplasms: A Case Report
Moreno, H. E. M., Díaz, F. V., Ramírez, C. A. D., Pantoja, L. F. S., & Franco, I. O. (2026) · Cureus · doi:10.7759/cureus.108926
Bayar, A., Yılmaz, A. F., Toptaş, T., ATAGÜNDÜZ, I., & Tuğlular, A. T. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-026-02419-2
CNS Involvement of Multiple Myeloma—A Case Series and Narrative Literature Review
Andrunache, A., Himcinschi, M., Barbu, S., Zidaru, L. E., Alexa, D., Popescu, M., Apuscaroaie, S. M., Popa, D. C., Ursuleac, I., Coriu, D., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103927
Ruiz, S., Compte, A., Mont-Castro, L. L., Pinilla, L., Tovar, D., Riera, E., & Garcia, J. R. (2026) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2026.500308
Yang, Z., Zhou, M., & Xiao, Y. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11171-z
Chatterjee, P., Kundu, A., Giri, S., & Basu, A. (2026) · Cureus · doi:10.7759/cureus.111117
Characterizing the Fate of Anti‐CS1 Nanobody Displaying Extracellular Vesicles in Multiple Myeloma
Coster, M. D., Hyka, L., Cock, S. D., Meeussen, S., Wang, Z., Tu, C., Hernot, S., Devoogdt, N., David, G., Veirman, K. D., et al. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70325
Karunathilake, P., Abeysinghe, N., Bowatte, S., Kumarihamy, P., Madegedara, D., Karunarathna, H., Katugahage, K., Mallikarachchi, V., Gardhiyawasam, A., & Rajapaksha, I. (2026) · Research Square · doi:10.21203/rs.3.rs-10096825/v1
Dung, N. N., Trang, P. T. T., Anh, P. T. N., Le Nhu, Y., Tùng, N. Q., & Anh, N. V. B. (2026) · International Journal of Surgery Case Reports · doi:10.1097/rc9.0000000000000601
Triggiani, D., Lisco, G., Renzulli, G., Mura, M. D., & Triggiani, V. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.06.011
Lymanets, T. V., Маслова, Г. С., Stadnik, Y. O., Gusachenko, I., & Havlovskyi, O. (2026) · Ukrainian Neurosurgical Journal · doi:10.25305/unj.349396
PET/CT Imaging for Therapy Assessment in Multiple Myeloma Including MRD
Daverio, A., Coccarelli, A., Henry, T., Danu, A., Agrigoroaie, L., Trabelsi, K., Kamoun, T., Rovera, G., Morbelli, S. D., & Deandreis, D. (2026) · Cancers · doi:10.3390/cancers18142184
Perioperative considerations for patients with multiple myeloma
Kallenbach, T. (2026) · European Journal of Anaesthesiology Intensive Care · doi:10.1097/ea9.0000000000000124
Multimodal imaging diagnosis of multiple myeloma with renal involvement: a case report
Zou, L.-L., & Ma, Y.-Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1881507
Wang, M., Wang, L., & Yuan, J. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117143
Heidemeier, A., Huflage, H., Rasche, L., Kortüm, K. M., Waldschmidt, J., Einsele, H., Bley, T. A., & Grunz, J. (2026) · Investigative Radiology · doi:10.1097/rli.0000000000001304
Self-citationZhou, Y.-N., Pan, Y., Liu, Y., Liu, J., Liu, Y., Liu, Y., Gu, W., & Cao, Y. (2026) · Discover Oncology · doi:10.1007/s12672-026-05643-4
When Myeloma Escapes the Bone Marrow: Extramedullary Disease in the Immunotherapy Era
Afrough, A., Dillard, C. M., Alsup, A., Lee, J. H., Hadidi, S. A., Sannareddy, A., Abraham, P. R., Turer, L., Dima, D., Khan, A. M., et al. (2026) · Cancers · doi:10.3390/cancers18152415
Peluso, S., Polizzi, S., Pagnini, L., Tarozzi, M. E., Rocchi, E., Dragonetti, V., Solli, V., Dall’Olio, D., Talarico, M., Terragna, C., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-08103-x
Self-citationJingliang, Z., Bai, Q., Qiu, Q., Song, J., Kong, S., Zhu, K., Zhang, Y., Li, S., Ma, Y., Zhang, L., et al. (2026) · Cancers · doi:10.3390/cancers18152484
Wang, Z., Ren, H., Wang, K., Zhang, X., Liu, C., Wu, H., Shi, J., Zhang, J., Wang, C., Wu, L., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.07.054
Singh, P. K., Ora, M., Verma, S., Maurya, R., Gautam, D., & Pratap, A. (2026) · Indian Journal of Nuclear Medicine · doi:10.25259/ijnm_64_2026
Teclistamab for ultrahigh-risk multiple myeloma with isolated central nervous system relapse
Xie, H., Luo, R., & Zeng, D. (2026) · Archives of Medical Science · doi:10.5114/aoms/230992
Fan, H., Feng, X., Wei, R., Zhang, X., Li, T., Liu, L., Wang, H., Sun, L., Shi, X., Zhao, H., et al. (2026) · Therapeutic Advances in Hematology · doi:10.1177/20406207261481202
Kuykendall, K., Adhikari, B., Carr, J., Gökden, N., van Rhee, F., Alapat, D. V., Schinke, C., & Aydın, A. M. (2026) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2026.08.015
Multiple myeloma presenting as pancoast tumour- A case report
Jayaprakash, B., Nandennavar, M., & Karpurmath, S. V. (2026) · South Asian Journal of Health Sciences · doi:10.25259/sajhs_36_2026
Plasmacytomas in Extramedullary Manifestation of Multiple Myeloma: A Case Report
Hmayed, J., Fadel, D., Albayeh, A., Jreij, C., Karam, K., Sett, L. E., & Fares, C. (2026) · Clinical Medicine Insights Case Reports · doi:10.1177/11795476261485712
Metadata
- Authors
- Bladé, J., Beksac, M., Caers, J., Jurczyszyn, A., von Lilienfeld-Toal, M., Moreau, P., Rasche, L., Rosiñol, L., Usmani, S. Z., Zamagni, E., & Richardson, P.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Centre Hospitalier Universitaire de Liège (BE)
- Jagiellonian University (PL)
- Nantes Université (FR)
- Universitätsklinikum Würzburg (DE)
- Levine Cancer Institute (US)
- Istituto di Ematologia di Bologna (IT)
- Harvard University (US)
- Corresponding author
- Bladé, Joan
- ORCID
- Venue
- Blood Cancer Journal
- Published
- 2022-03-21
- Volume
- 12
- Issue
- 3
- Pages
- 45-45
- ISSN
- 2044-5385 (ISSN-L)
- PMC
- PMC8938478
- OpenAlex
- W4220896277
- Cited by
- 319
- References
- 56
- Citations by year
- 2026: 79 · 2025: 107 · 2024: 73 · 2023: 44 · 2022: 14
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Blood Cancer Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion, cc-by)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Surgery › Management of metastatic bone disease
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- extramedullary disease, multiple myeloma, soft tissue plasmacytoma, hematogenous spread, relapsed/refractory multiple myeloma, central nervous system involvement, leptomeningeal involvement, prognosis, treatment outcomes
- MeSH terms
- Humans, Multiple Myeloma, Neoplasm Recurrence, Local, Plasmacytoma, Prospective Studies, Retrospective Studies, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
